These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1124067)

  • 1. [Transfer mechanisms and biologic availability of drugs].
    Med Monatsschr; 1975 Mar; 29(3):97-8. PubMed ID: 1124067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biologic availability of drugs].
    Stössel JP
    Tierarztl Prax; 1975; 3(1):109-12. PubMed ID: 1198586
    [No Abstract]   [Full Text] [Related]  

  • 3. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-availability and its clinical implications.
    Richens A
    Trans Med Soc Lond; 1975; 91():18-22. PubMed ID: 800695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the biologic availability of drugs under clinical conditions].
    Cepelák V; Mayer O; Cepeláková H; Vitous J; Petrlík M
    Cesk Farm; 1977 Mar; 26(2):59-64. PubMed ID: 577192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enteral availability and suggested dosages for methyl proscillaridin in decompensated heart patients].
    Krämer KD; Hochrein H
    Verh Dtsch Ges Inn Med; 1975; 81():1669-71. PubMed ID: 1227053
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biologic availability of drugs in humans and animals].
    Wichliński L
    Pol Tyg Lek; 1975 Dec; 30(50):2111-2. PubMed ID: 1197106
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability: some pharmaceutical factors.
    Fowle AS
    Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on absorption and elimination of drugs. Part IV. Computer evaluation of pharmacokinetic parameters of the two compartment open model.
    Ksiezyk M; Danek A
    Pol J Pharmacol Pharm; 1975; 27(5):567-77. PubMed ID: 1187459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of biologic availability of active principles contained in galenic forms for cutaneous administration].
    Aiache JM; Aiache S; Guilpain G; Paire M
    Boll Chim Farm; 1977 Feb; 116(2):63-80. PubMed ID: 861080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of the starting materials on bioavailability of drugs].
    Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
    Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is the resorption of gram doses of ascorbic acid better from the resorption-delaying preparations? Discussion].
    Kübler W; Westphal J; Brenner G; Siegers CP; Seidel G; Iven H
    Med Klin; 1976 Sep; 71(36):1447-51. PubMed ID: 958110
    [No Abstract]   [Full Text] [Related]  

  • 14. [Age-related aspects of pharmacokinetics (a review of the literature)].
    Bezverkhaia IS; Zapadniuk VI
    Farmakol Toksikol; 1980; 43(1):115-9. PubMed ID: 6991280
    [No Abstract]   [Full Text] [Related]  

  • 15. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bioavailability data by practitioners. I: pitfalls in interpreting the data.
    Schumacher GE
    Am J Hosp Pharm; 1975 Aug; 32(8):639-42. PubMed ID: 1146833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partitioning phenomena in dosage form and biopharmaceutical design. I. Prognostic significance of partition coefficients.
    Am J Hosp Pharm; 1971 Oct; 28(10):796-9. PubMed ID: 5125175
    [No Abstract]   [Full Text] [Related]  

  • 18. [In-vitro transfer of oxytetracycline and doxycycline from various types of ointment excipients].
    Papini P; Bramanti G; Mazzi G; Grati G
    Boll Chim Farm; 1976 May; 115(5):398-406. PubMed ID: 1008945
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological availability of digoxin in combination drugs].
    Gilfrich HJ; Clasen R
    Verh Dtsch Ges Inn Med; 1975; 81():1666-9. PubMed ID: 1227052
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bioavailability and biopharmaceutics].
    Colombo BM; Colombo MM; De Fusco R
    Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.